UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Furazans in Medicinal Chemistry

Journal of medicinal chemistry, 2021-02, Vol.64 (4), p.1786-1815

2021

Volltextzugriff (PDF)

Oxadiazoles in Medicinal Chemistry

Journal of medicinal chemistry, 2012-03, Vol.55 (5), p.1817-1830

2012

Volltextzugriff (PDF)

Multistep Synthesis of Analogues of Remdesivir: Incorporating Heterocycles at the C‑1′ Position

Journal of organic chemistry, 2023-07, Vol.88 (13), p.9105-9122

2023

Volltextzugriff (PDF)

Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

The Lancet (British edition), 2021-09, Vol.398 (10306), p.1184-1194

2021

Volltextzugriff (PDF)

Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABA A receptor

European journal of medicinal chemistry, 2020-11, Vol.206, p.112672

2020

Volltextzugriff (PDF)

The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization

Journal of molecular biology, 2014-04, Vol.426 (8), p.1848-1860

2014

Volltextzugriff (PDF)

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Lancet neurology, 2016-02, Vol.15 (2), p.154-165

2016

Volltextzugriff (PDF)

Ozanimod: First Approval

Drugs (New York, N.Y.), 2020-06, Vol.80 (8), p.841-848

Lamb, Yvette N.

2020

Volltextzugriff (PDF)

New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies

European journal of medicinal chemistry, 2019-12, Vol.183, p.111693, Article 111693

2019

Volltextzugriff (PDF)

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Nature (London), 2017-03, Vol.543 (7645), p.428-432

2017

Volltextzugriff (PDF)

Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review

European journal of medicinal chemistry, 2021-01, Vol.209, p.112886-112886, Article 112886

2021

Volltextzugriff (PDF)

Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic

Journal of medicinal chemistry, 2022-05, Vol.65 (9), p.6612-6630

2022

Volltextzugriff (PDF)

Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives

Chemical and Pharmaceutical Bulletin, 2019/08/01, Vol.67(8), pp.888-895

2019

Volltextzugriff (PDF)

Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents

European journal of medicinal chemistry, 2021-01, Vol.209, p.112874, Article 112874

2021

Volltextzugriff (PDF)

Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis

European journal of medicinal chemistry, 2016-11, Vol.123, p.523-531

2016

Volltextzugriff (PDF)

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

JAMA neurology, 2015-11, Vol.72 (11), p.1324

2015

Volltextzugriff (PDF)

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Journal of clinical pharmacology, 2017-08, Vol.57 (8), p.988-996

2017

Volltextzugriff (PDF)

Synthesis and antimicrobial activity of pyrimidinyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles

European journal of medicinal chemistry, 2018-02, Vol.145, p.1-10

2018

Volltextzugriff (PDF)

Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6

Journal of medicinal chemistry, 2023-10, Vol.66 (19), p.13821-13837

2023

Volltextzugriff (PDF)

1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities

Bioorganic & medicinal chemistry, 2017-08, Vol.25 (15), p.4064-4075

2017

Volltextzugriff (PDF)

Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria

Journal of medicinal chemistry, 2022-04, Vol.65 (8), p.6171-6190

2022

Volltextzugriff (PDF)

Novel 1,3,4-Oxadiazole-2-carbohydrazides as Prospective Agricultural Antifungal Agents Potentially Targeting Succinate Dehydrogenase

Journal of agricultural and food chemistry, 2019-12, Vol.67 (50), p.13892-13903

2019

Volltextzugriff (PDF)

Discovery of 5‑(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma

Journal of medicinal chemistry, 2024-07, Vol.67 (13), p.10622-10642

2024

Volltextzugriff (PDF)

1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells

Journal of medicinal chemistry, 2014-07, Vol.57 (14), p.6259-6265

2014

Volltextzugriff (PDF)

1 – 25 von 4.899

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.483)
Mit Volltextzugriff
(4.200)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.555)
IngentaConnect
(2.649)
EZB Electronic Journals Library
(1.665)
Elsevier ScienceDirect Journals Complete
(1.539)
Journals@Ovid
(1.500)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.494)
Wiley-Blackwell Journals
(845)
IngentaConnect Journals
(753)
Wiley Online Library Full Collection 2018
(612)
Standalone journals
(591)
Springer journals
(348)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(272)
Taylor & Francis
(118)
Taylor & Francis Journals
(110)
Taylor & Francis Journals Complete
(105)
Oxford journals
(76)
Springer Nature - Connect here FIRST to enable access
(72)
JSTOR
(62)
Nexis Uni (LexisNexis)
(57)
Oxford Journals 2020 Medicine
(55)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Furazans in Medicinal Chemistry

Oxadiazoles in Medicinal Chemistry

Multistep Synthesis of Analogues of Remdesivir: Incorporating Heterocycles at the C‑1′ Position

Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABA A receptor

The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Ozanimod: First Approval

New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review

Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor

Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic

Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives

Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents

Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator

Synthesis and antimicrobial activity of pyrimidinyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles

Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6

1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities

Unique Carbazole-Oxadiazole Derivatives as New Potential Antibiotics for Combating Gram-Positive and -Negative Bacteria

Novel 1,3,4-Oxadiazole-2-carbohydrazides as Prospective Agricultural Antifungal Agents Potentially Targeting Succinate Dehydrogenase

Discovery of 5‑(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma

1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells

Suchergebnisse filtern